Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to ...

Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinionRecommendation for adults and ...

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted an opinion recommending the approval of ...

Sanofi ( NASDAQ: SNY) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...

A woman has shared devastating home camera footage capturing the last time she heard her 15-year-old son Parker's voice. Jess Coats, 47, told Newsweek: "His last moments on camera are hard to watch—my ...

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

LONDON (Reuters) -Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after late-stage trial data for its experimental inflammatory ...

As Micah Parsons gets his start with the Green Bay Packers, his first appearance with the team might be up in the air. Parsons has been dealing with a L4/L5 facet joint sprain in the vertebrae in his ...

"For the new songs, we took so much time just to make sure everything is fine and powerful enough." "Also, we don't have that much pressure. We are not a young band anymore… We've been a band for 30 ...

Sanofi’s amlitelimab met trial endpoints but lagged Dupixent and rivals in strength. Shares fell as investors doubted its potential as a true Dupixent successor. Want to trade this news? Get access to ...

The FDA has approved a new injectable version of cancer drug Keytruda as Merck seeks to protect its market dominance.  Here are five things to know: ...